CLDN25
gene geneOn this page
Summary
CLDN25 (claudin 25, HGNC:37218) is a protein-coding gene on chromosome 11q23.2, encoding Claudin-25 (C9JDP6). Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions.
Source: NCBI Gene 644672 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_001101389
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37218 |
| Approved symbol | CLDN25 |
| Name | claudin 25 |
| Location | 11q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000228607 |
| Ensembl biotype | protein_coding |
| OMIM | 620812 |
| Entrez | 644672 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000453129
RefSeq mRNA: 1 — MANE Select: NM_001101389
NM_001101389
CCDS: CCDS44736
Canonical transcript exons
ENST00000453129 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001702676 | 113779796 | 113780485 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 52.00.
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory segment of nasal mucosa | UBERON:0005386 | 52.00 | gold quality |
| adenohypophysis | UBERON:0002196 | 39.60 | gold quality |
| granulocyte | CL:0000094 | 38.95 | gold quality |
| pituitary gland | UBERON:0000007 | 37.46 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.40 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| muscle of leg | UBERON:0001383 | 28.65 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| gastrocnemius | UBERON:0001388 | 28.00 | gold quality |
| leukocyte | CL:0000738 | 27.86 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| monocyte | CL:0000576 | 27.18 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.15 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| uterine cervix | UBERON:0000002 | 25.56 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| cortex of kidney | UBERON:0001225 | 23.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cldn25 | ENSMUSG00000105298 |
| rattus_norvegicus | Cldn25 | ENSRNOG00000057454 |
Paralogs (22): CLDN11 (ENSG00000013297), CLDN18 (ENSG00000066405), CLDN15 (ENSG00000106404), CLDN16 (ENSG00000113946), CLDN10 (ENSG00000134873), CLDN17 (ENSG00000156282), CLDN8 (ENSG00000156284), CLDN14 (ENSG00000159261), CLDN1 (ENSG00000163347), CLDN19 (ENSG00000164007), CLDN3 (ENSG00000165215), CLDN2 (ENSG00000165376), CLDN20 (ENSG00000171217), CLDN22 (ENSG00000177300), CLDN7 (ENSG00000181885), CLDN5 (ENSG00000184113), CLDN6 (ENSG00000184697), CLDN24 (ENSG00000185758), CLDN4 (ENSG00000189143), CLDN9 (ENSG00000213937), CLDN34 (ENSG00000234469), CLDN23 (ENSG00000253958)
Protein
Protein identifiers
Claudin-25 — C9JDP6 (reviewed: C9JDP6)
All UniProt accessions (1): C9JDP6
UniProt curated annotations — full annotation on UniProt →
Function. Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Subcellular location. Cell junction. Tight junction. Cell membrane.
Similarity. Belongs to the claudin family.
RefSeq proteins (1): NP_001094859* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004031 | PMP22/EMP/MP20/Claudin | Family |
| IPR006187 | Claudin | Family |
Pfam: PF00822
UniProt features (11 total): topological domain 5, transmembrane region 4, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9JDP6-F1 | 82.88 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 11 (showing top):
GOCC_CELL_CELL_JUNCTION, GOCC_ANCHORING_JUNCTION, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOCC_TIGHT_JUNCTION, GOCC_APICAL_JUNCTION_COMPLEX, KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY, GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN, GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN, chr11q23, GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP, GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP
GO Biological Process (2): cell adhesion (GO:0007155), bicellular tight junction assembly (GO:0070830)
GO Molecular Function (1): structural molecule activity (GO:0005198)
GO Cellular Component (5): plasma membrane (GO:0005886), bicellular tight junction (GO:0005923), tight junction (GO:0070160), membrane (GO:0016020), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 1 |
| apical junction assembly | 1 |
| tight junction assembly | 1 |
| molecular_function | 1 |
| membrane | 1 |
| cell periphery | 1 |
| apical junction complex | 1 |
| tight junction | 1 |
| cell-cell junction | 1 |
| cellular anatomical structure | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
1615 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLDN25 | CLDN34 | H7C241 | 582 |
| CLDN25 | CLDN17 | P56750 | 500 |
| CLDN25 | CLDN16 | Q9Y5I7 | 484 |
| CLDN25 | CLDN12 | P56749 | 480 |
| CLDN25 | CLDN8 | P56748 | 440 |
| CLDN25 | CLDN11 | O75508 | 412 |
| CLDN25 | TJP3 | O95049 | 345 |
| CLDN25 | CLDND1 | Q9NY35 | 342 |
| CLDN25 | MARVELD2 | Q8N4S9 | 322 |
| CLDN25 | MRM2 | Q9UI43 | 316 |
| CLDN25 | J3KSM2 | J3KSM2 | 308 |
| CLDN25 | CLDN23 | Q96B33 | 286 |
| CLDN25 | F11R | Q9Y624 | 270 |
| CLDN25 | TJP2 | Q9UDY2 | 266 |
| CLDN25 | MARVELD1 | Q9BSK0 | 262 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A6NDP7, A6NFC5, A8MUP6, B1AQL3, B2RZ87, C9JDP6, E9Q9H8, O75204, P0C5X8, Q02644, Q08DL4, Q0IIL2, Q16617, Q1HG44, Q2KIG8, Q2KJ11, Q2KJ98, Q3SZ72, Q3SZT1, Q3UUA0, Q3YBM2, Q497B3, Q53RY4, Q5R8D6, Q6AYL2, Q6ICI0, Q7YQI4, Q7Z7M1, Q7Z7N9, Q80WE5, Q8BGP5, Q8CIP5, Q8K177, Q8R1W2, Q8WXS4, Q95KI5, Q96B33, Q96DZ7, Q96HP8, Q96JT2
Diamond homologs: A0A8C0N7E5, A6NM45, C3VMW3, C9JDP6, D3ZQJ0, O00501, O14493, O15551, O19005, O35054, O54942, O75508, O88551, O88552, O95471, O95484, O95500, O95832, P56745, P56746, P56747, P56748, P56750, P56856, P56857, P56880, P57739, P78369, Q0VCN0, Q2HJ22, Q2KIY2, Q3B7N4, Q3MHK4, Q4R3L1, Q5E9L0, Q5I0E5, Q5QT56, Q5R8E5, Q60771, Q63400
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
187 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:113779970:G:GT | donor_gain | 0.9100 |
| 11:113779970:G:T | donor_gain | 0.9100 |
| 11:113779991:GCC:G | donor_gain | 0.8900 |
| 11:113780049:T:TA | donor_gain | 0.8700 |
| 11:113780050:A:AA | donor_gain | 0.8700 |
| 11:113779983:TGTGC:T | donor_gain | 0.8400 |
| 11:113779985:TGC:T | donor_gain | 0.8300 |
| 11:113780027:CAG:C | donor_loss | 0.8000 |
| 11:113780028:AGG:A | donor_loss | 0.8000 |
| 11:113780029:GG:G | donor_loss | 0.8000 |
| 11:113780030:GTA:G | donor_loss | 0.8000 |
| 11:113780031:T:C | donor_loss | 0.8000 |
| 11:113779987:C:T | donor_gain | 0.7900 |
| 11:113780112:A:AG | acceptor_gain | 0.7200 |
| 11:113780113:G:GG | acceptor_gain | 0.7200 |
| 11:113779894:G:GT | donor_gain | 0.7100 |
| 11:113779949:G:T | donor_gain | 0.6900 |
| 11:113779813:TGCAA:T | donor_gain | 0.6800 |
| 11:113780113:GT:G | acceptor_gain | 0.6700 |
| 11:113779954:C:A | donor_gain | 0.6600 |
| 11:113780110:CCA:C | acceptor_loss | 0.6500 |
| 11:113780113:G:A | acceptor_loss | 0.6500 |
| 11:113780395:T:A | acceptor_gain | 0.6500 |
| 11:113779949:G:GT | donor_gain | 0.6400 |
| 11:113779910:G:GT | donor_gain | 0.6200 |
| 11:113780021:G:GT | donor_gain | 0.6100 |
| 11:113780391:T:TA | acceptor_gain | 0.5900 |
| 11:113779952:GTC:G | donor_gain | 0.5800 |
| 11:113779953:TCT:T | donor_gain | 0.5800 |
| 11:113780211:G:A | acceptor_gain | 0.5700 |
AlphaMissense
1476 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:113780237:T:C | F148L | 0.912 |
| 11:113780239:C:A | F148L | 0.912 |
| 11:113780239:C:G | F148L | 0.912 |
| 11:113779994:T:C | F67L | 0.882 |
| 11:113779996:T:A | F67L | 0.882 |
| 11:113779996:T:G | F67L | 0.882 |
| 11:113779894:G:C | W33C | 0.877 |
| 11:113779894:G:T | W33C | 0.877 |
| 11:113779892:T:A | W33R | 0.833 |
| 11:113779892:T:C | W33R | 0.833 |
| 11:113780275:G:C | W160C | 0.828 |
| 11:113780275:G:T | W160C | 0.828 |
| 11:113779948:G:C | W51C | 0.811 |
| 11:113779948:G:T | W51C | 0.811 |
| 11:113779897:G:C | K34N | 0.808 |
| 11:113779897:G:T | K34N | 0.808 |
| 11:113780303:T:A | W170R | 0.781 |
| 11:113780303:T:C | W170R | 0.781 |
| 11:113779856:T:A | W21R | 0.751 |
| 11:113779856:T:C | W21R | 0.751 |
| 11:113780279:T:C | F162L | 0.751 |
| 11:113780281:T:A | F162L | 0.751 |
| 11:113780281:T:G | F162L | 0.751 |
| 11:113779933:G:C | W46C | 0.740 |
| 11:113779933:G:T | W46C | 0.740 |
| 11:113779893:G:T | W33L | 0.711 |
| 11:113780003:T:C | F70L | 0.710 |
| 11:113780005:C:A | F70L | 0.710 |
| 11:113780005:C:G | F70L | 0.710 |
| 11:113779893:G:C | W33S | 0.707 |
dbSNP variants (sampled 300 via entrez): RS1000552043 (11:113778279 G>A), RS1000587808 (11:113778052 C>G,T), RS1002060944 (11:113778716 C>T), RS1002495449 (11:113778419 C>T), RS1003089659 (11:113779707 C>A,T), RS1004728169 (11:113778726 A>C,G,T), RS1005508833 (11:113778770 C>T), RS1007283022 (11:113780407 C>A,T), RS1007355320 (11:113780719 C>A), RS1009352484 (11:113778640 G>A,C), RS1009384960 (11:113778343 C>T), RS1010388994 (11:113779650 C>G), RS1010662364 (11:113778090 A>G), RS1011446276 (11:113780796 C>A), RS1011636984 (11:113779177 T>G)
Disease associations
OMIM: gene MIM:620812 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| maleic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.